A 'dead' CRISPR might be a better CRISPR for targeting Alzheimer's
Read now →A new molecular editor based on "dead Cas9" shows encouraging results for editing the genome
Charlotte Douglas
Genetics
Institut Curie Paris
Dr Charlotte Douglas has a PhD in sex chromosome biology and developmental genetics from the Francis Crick Institute and King’s College London where her expertise was in genetics and new ways to implement CRISPR-Cas9 technologies. She loves to think about how CRISPR tools and transgenics can be modified and reapplied to solve translational problems.
She is now a post-doctoral researcher at the Institut Curie in Paris, where she aims to investigate the role and function of RNA methylation. This is a completely new field for her, and she’s excited to dip a toe in a quickly expanding and exciting area of science!
Overall, Charlotte she loves understanding how new genome editing and gene therapy tools could be used to progress healthcare science. She would love to connect with others in the science and SciComm world, so please feel free to get in touch!
A new molecular editor based on "dead Cas9" shows encouraging results for editing the genome
Prime editing, which edits DNA directly without cutting, restored healthy function in an organoid model of an intestine
The advance could generate new solutions to for human fertility issues
An embryonic phenomenon discovered over 150 years ago may finally have an explanation